WO2021026479A9 - Small molecule inhibitors of s1p2 receptor and uses thereof - Google Patents

Small molecule inhibitors of s1p2 receptor and uses thereof Download PDF

Info

Publication number
WO2021026479A9
WO2021026479A9 PCT/US2020/045455 US2020045455W WO2021026479A9 WO 2021026479 A9 WO2021026479 A9 WO 2021026479A9 US 2020045455 W US2020045455 W US 2020045455W WO 2021026479 A9 WO2021026479 A9 WO 2021026479A9
Authority
WO
WIPO (PCT)
Prior art keywords
receptor
small molecule
molecule inhibitors
compounds
het1
Prior art date
Application number
PCT/US2020/045455
Other languages
French (fr)
Other versions
WO2021026479A1 (en
Inventor
Teresa Sanchez
Lee YUN-KYOUNG
William J. Polvino
Yasufimi WADA
Yoshiyuki Fukase
Asato Kina
Hiroki TAKAHAGI
Hideyuki Igawa
Peter Meinke
Michael Foley
Ayumu Sato
Sabyasachi DASH
Original Assignee
Stamford, Andrew
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stamford, Andrew filed Critical Stamford, Andrew
Publication of WO2021026479A1 publication Critical patent/WO2021026479A1/en
Publication of WO2021026479A9 publication Critical patent/WO2021026479A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/12—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

The present disclosure provides a compound of the formula Het1-L1-Ar1-L2-G1, or a pharmaceutically acceptable salt, polymorph, prodrug, solvate or clathrate thereof, that are useful for treating a variety of conditions. In such compounds, Het1, G1, Ar1, L1, and L2 are as defined herein. Pharmaceutical compositions of such compounds are also contemplated.
PCT/US2020/045455 2019-08-07 2020-08-07 Small molecule inhibitors of s1p2 receptor and uses thereof WO2021026479A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962884046P 2019-08-07 2019-08-07
US62/884,046 2019-08-07

Publications (2)

Publication Number Publication Date
WO2021026479A1 WO2021026479A1 (en) 2021-02-11
WO2021026479A9 true WO2021026479A9 (en) 2021-04-08

Family

ID=74504178

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2020/045455 WO2021026479A1 (en) 2019-08-07 2020-08-07 Small molecule inhibitors of s1p2 receptor and uses thereof

Country Status (1)

Country Link
WO (1) WO2021026479A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113979891A (en) * 2021-11-08 2022-01-28 上海高准医药有限公司 Preparation method of Cliborol and intermediate product thereof
CN115433107A (en) * 2022-09-19 2022-12-06 南京欧际医药科技服务有限公司 S1PR2 antagonist and application thereof in preparation of drugs for treating lung diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ589617A (en) * 2008-05-14 2012-06-29 Scripps Research Inst 3-(Inden-4-yl)-5-(phenyl)-1,2,4-oxadiazole and 3-(tetralin-5-yl)-5-(phenyl)-1,2,4-oxadiazole derivatives
BR112015024897A2 (en) * 2013-03-26 2017-07-18 Ono Pharmaceutical Co phenyl derivative
US20150051176A1 (en) * 2013-08-15 2015-02-19 Allergan, Inc. Aryl derivatives as sphingosine-1 phosphate receptors modulators

Also Published As

Publication number Publication date
WO2021026479A1 (en) 2021-02-11

Similar Documents

Publication Publication Date Title
MX2020006315A (en) Triazole n-linked carbamoyl cyclohexyl acids as lpa antagonists.
MX2021013075A (en) Oxysterols and methods of use thereof.
WO2015200481A8 (en) Mnk inhibitors and methods related thereto
MX2020005363A (en) Heterocyclic compounds as prmt5 inhibitors.
MX2020005323A (en) Cyclohexyl acid triazole azines as lpa antagonists.
MX354175B (en) Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation.
MX2020005818A (en) Cyclohexyl acid triazole azoles as lpa antagonists.
PH12019550140A1 (en) Piperidine-substituted mnk inhibitors and methods related thereto
MX2009012847A (en) Dipeptide analogs as coagulation factor inhibitors.
WO2009155121A3 (en) Inhibitors of pi3 kinase
MX2014012741A (en) Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation.
SE0400284D0 (en) Novel compounds
MX2021011606A (en) Compounds targeting prmt5.
PH12020552244A1 (en) Heterocyclic compounds as trk inhibitors
EA201891578A1 (en) COMPOSITIONS OF 2- (4-CHLOROPHENIL) -N - ((2- (2,6-DIOXOPIPERIDIN-3-IL) -1-OXYOISOINDOLIN-5-IL) METHYL-2,2-DIPHTORACETAMIDE
PH12020550265A1 (en) Benzimidazole derivatives and their uses
WO2021026479A9 (en) Small molecule inhibitors of s1p2 receptor and uses thereof
MX2020001531A (en) Novel heterocyclic compounds as cdk8/19 inhibitors.
WO2018035346A8 (en) Kinase inhibitor compounds, compositions, and methods of treating cancer
PH12019550154A1 (en) Azetidine derivative
MX2021012105A (en) Pyrrole compounds.
MX2022007171A (en) Cyclic compounds and methods of using same.
JOP20220084A1 (en) 5-oxa-2-azaspiro[3.4]octane derivatives as m4 agonists
JOP20220082A1 (en) 2-azaspiro[3.4]octane derivatives as m4 agonists
WO2019161157A8 (en) P300/cbp hat inhibitors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20849951

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20849951

Country of ref document: EP

Kind code of ref document: A1